Does CABAZITAXEL Cause Decreased appetite? 89 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 89 reports of Decreased appetite have been filed in association with CABAZITAXEL (Jevtana). This represents 3.5% of all adverse event reports for CABAZITAXEL.
89
Reports of Decreased appetite with CABAZITAXEL
3.5%
of all CABAZITAXEL reports
18
Deaths
52
Hospitalizations
How Dangerous Is Decreased appetite From CABAZITAXEL?
Of the 89 reports, 18 (20.2%) resulted in death, 52 (58.4%) required hospitalization, and 4 (4.5%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for CABAZITAXEL.
What Other Side Effects Does CABAZITAXEL Cause?
Febrile neutropenia (197)
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Disease progression (143)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which CABAZITAXEL Alternatives Have Lower Decreased appetite Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE